Stephens Consulting’s Zevra Therapeutics ZVRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,000
Closed -$6.94K 548
2024
Q3
$6.94K Hold
1,000
﹤0.01% 370
2024
Q2
$4.9K Sell
1,000
-1,000
-50% -$4.74K ﹤0.01% 407
2024
Q1
$11.6K Hold
2,000
﹤0.01% 297
2023
Q4
$13.1K Hold
2,000
﹤0.01% 285
2023
Q3
$9.64K Hold
2,000
﹤0.01% 314
2023
Q2
$10.2K Hold
2,000
﹤0.01% 307
2023
Q1
$11K Hold
2,000
0.01% 306
2022
Q4
$9.18K Hold
2,000
0.01% 311
2022
Q3
$12.5K Hold
2,000
0.01% 296
2022
Q2
$8.92K Hold
2,000
0.01% 342
2022
Q1
$10.1K Sell
2,000
-225
-10% -$1.43K 0.01% 352
2021
Q4
$19.4K Buy
+2,225
New +$19.9K 0.02% 297

Other funds holding ZVRA